Engineering heterogeneity of precision nanoparticles for biomedical delivery and therapy

Abstract

Nanoparticle (NP)‐based vehicles are attractive for biomedical delivery and therapy, owing to improved therapeutic efficiency and reduced adverse effects compared to free drugs. Uncontrolled NP heterogeneity at the suspension level or single particle level poses grand challenges in the effective use of NPs for biology and medicines. Precision nanoparticles (PNPs) are a class of discrete nanostructures exhibiting elaborately tailored surface or structural heterogeneity, but minimal variations between nanostructures in one solution. Benefiting from their precisely controlled NP heterogeneity, PNPs have emerged as promising platforms for modulating various biological processes to improve the biomedical performance of NP‐based vehicles. This review summarizes recent advances in the development of precisely tailored PNPs for biomedical applications, with an emphasis on the nano‐bio interactions, and drug delivery and therapy. We start with a brief overview of the major categories of PNPs and their fabrication strategies (section 2). We then focus on reviewing the use of PNPs for enhancing biomolecular recognition or detection, regulating the NP‐protein interactions, modulating the NP‐biomembrane interactions, and improving the biological delivery and therapy (section 3). Finally, we discuss the challenges and perspectives on the design and use of PNPs for biomedical applications (section 4).

Biodegradable and biocompatible exceedingly small magnetic iron oxide nanoparticles for T1-weighted magnetic resonance imaging of tumors

“…Magnetic resonance imaging (MRI) has been widely using in clinical diagnosis and prognosis observation to distinguish lesions from normal tissues, especially for the diagnosis of tumors, because of its obvious superiorities, including high soft tissue contrast, high spatial resolution, non-invasion and non-radiation [1][2][3][4]. Contrast agents (CAs) play an indispensable role to enhance the sensitivity of MRI.…”

H2O2-Activatable Antioxidant Polymeric Prodrug Nanoparticles for the Prevention of Renal Ischemia/Reperfusion Injury

“…Enormous efforts have been dedicated to exploring the use of nanoparticle-based drug delivery systems that could improve the pharmacokinetics and biodistribution of drugs, leading to enhanced therapeutic efficacy. , In the design of drug delivery systems, the ratio of drugs to nanoparticles predominantly determines their therapeutic efficacy and toxicity because nanoparticles are only an excipient for drug delivery that has no therapeutic actions . In general, polymeric drug delivery systems have a drug loading capacity as high as <20 wt %. , If drugs have low therapeutic potency, a large number of drug delivery systems are required to exert sufficient therapeutic actions, which leads to toxicity resulting from the poor metabolism and elimination of nanoparticles.…”

Polymer-Tethered Nanoparticles: From Surface Engineering to Directional Self-Assembly

“…40 The heterogeneity of NP surface chemistry modulates their distribution in vivo, 41−43 an effect that may originate from the sensitivity of biological systems to the surface architecture of foreign nano-objects. 44 Increasing efforts have focused on the generation of patchy NPs with controlled position and number of patches per NP. 45−53 Recently, we developed a thermodynamically mediated approach to the generation of patchy NPs tethered to end-grafted polymers.…”